These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.

View All HCPCS Sections

• J3263

  Injection, toripalimab-tpzi, 1 mg

• J3265

  Injection, torsemide, 10 mg/ml

• J3280

  Injection, thiethylperazine maleate, up to 10 mg

• J3285

  Injection, treprostinil, 1 mg

• J3290

  Injection, tranexamic acid, 5 mg

• J3291

  Injection, tranexamic acid in sodium chloride, 5 mg

• J3299

  Injection, triamcinolone acetonide (xipere), 1 mg

• J3300

  Injection, triamcinolone acetonide, preservative free, 1 mg

• J3301

  Injection, triamcinolone acetonide, not otherwise specified, 10 mg

• J3302

  Injection, triamcinolone diacetate, per 5 mg

• J3303

  Injection, triamcinolone hexacetonide, per 5 mg

• J3304

  Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg

• J3305

  Injection, trimetrexate glucuronate, per 25 mg

• J3310

  Injection, perphenazine, up to 5 mg

• J3315

  Injection, triptorelin pamoate, 3.75 mg

• J3316

  Injection, triptorelin, extended-release, 3.75 mg

• J3320

  Injection, spectinomycin dihydrochloride, up to 2 gm

• J3350

  Injection, urea, up to 40 gm

• J3355

  Injection, urofollitropin, 75 iu

• J3357

  Ustekinumab, for subcutaneous injection, 1 mg

• J3358

  Ustekinumab, for intravenous injection, 1 mg

• J3360

  Injection, diazepam, up to 5 mg

• J3364

  Injection, urokinase, 5000 iu vial

• J3365

  Injection, iv, urokinase, 250,000 i.u. vial

• J3370

  Injection, vancomycin hcl, 500 mg

• J3371

  Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg

• J3372

  Injection, vancomycin hcl (xellia), not therapeutically equivalent to j3370, 500 mg

• J3373

  Injection, vancomycin hydrochloride, 10 mg

• J3374

  Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mg

• J3375

  Injection, vancomycin hydrochloride (xellia), not therapeutically equivalent to j3373, 10 mg

• J3376

  Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mg

• J3379

  Injection, valproate sodium, 5 mg

• J3380

  Injection, vedolizumab, intravenous, 1 mg

• J3385

  Injection, velaglucerase alfa, 100 units

• J3387

  Injection, elivaldogene autotemcel, per treatment

• J3389

  Topical administration, prademagene zamikeracel, per treatment

• J3391

  Injection, atidarsagene autotemcel, per treatment

• J3392

  Injection, exagamglogene autotemcel, per treatment

• J3393

  Injection, betibeglogene autotemcel, per treatment

• J3394

  Injection, lovotibeglogene autotemcel, per treatment

• J3396

  Injection, verteporfin, 0.1 mg

• J3397

  Injection, vestronidase alfa-vjbk, 1 mg

• J3398

  Injection, voretigene neparvovec-rzyl, 1 billion vector genomes

• J3399

  Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes

• J3400

  Injection, triflupromazine hcl, up to 20 mg

• J3401

  Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml

• J3402

  Injection, remestemcel-l-rknd, per therapeutic dose

• J3403

  Revakinagene taroretcel-lwey, per implant

• J3404

  Injection, zopapogene imadenovec-drba suspension, per therapeutic dose

• J3410

  Injection, hydroxyzine hcl, up to 25 mg

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/4/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.